Amniotic fluid bilirubin measurement: a comparison of five methods by Savell, Jonathan
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
1967
Amniotic fluid bilirubin measurement: a
comparison of five methods
Jonathan Savell
Yale University
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Savell, Jonathan, "Amniotic fluid bilirubin measurement: a comparison of five methods" (1967). Yale Medicine Thesis Digital Library.
3130.
http://elischolar.library.yale.edu/ymtdl/3130
YALE UNIVERSITY LIBRARY 
3 9002 06679 1832 
'• ' ■ ' ; ■ ■ ■ ' : 







AMNIOTIC FLUID BILIRUBIN MEASUREMENT: 
A COMPARISON OF FIVE METHODS 
Jonathan Saveli 
A.B. Columbia College, 1963 
A Thesis Presented to the 
Faculty of the School of Medicine 
Yale University 
in Partial Fulfillment of the 
Requirements for the Degree of 
Doctor of Medicine 
Department of Obstetrics and Gynecology 






I would like to express my gratitude for the help given me by 
Dr. Maclyn E. Wade, my thesis advisor, whose clinical and research 
achievements have been an inspiration to me. 
For her help in drawing graphs, and typing this thesis, my 
grateful thanks go to my wife, Cynthia. 
Digitized by the Internet Archive 
in 2017 with funding from 
The National Endowment for the Humanities and the Arcadia Fund 
https://archive.org/details/amnioticfluidbilOOsave 
Table of Contents 
Pages 
I. Introduction 1 
II. Method 2 - 8 
III. Results 9 - 10 
IV. Dis cussion 11 - 19 




Since Bevls (1) first showed a correlation between the severity 
of hemolytic disease of the newborn and the amounts of several sub¬ 
stances present in the amniotic fluid, amniocentesis has been wide¬ 
ly used as a diagnostic aid in this disease. Liley (13, 14) showed 
that the most important of these substances was bilirubin, which he 
measured using a direct spectrophotometric method. Results were ex¬ 
pressed in optical density units. 
'Although most workers since then have been satisfied with Liley’s 
method, others have attempted to quantitate bilirubin levels in am¬ 
niotic fluid. Robertson (19), Bower and Swale (2), Watson and Mackey 
(22), and Freda (8) used various diazotization techniques for this 
purpose. Fleming and Woolf devised another direct spectrophotometric 
method, which unlike Liley’s was quantitated to give results in mg. 
per cent of bilirubin (5). 
This paper will compare several of these methods for measuring 





After localization of the placenta with radioactive I labeled 
albumin, amniotic fluid was obtained by transabdominal percutaneous 
puncture with a 20 gauge spinal needle. Ten to fifteen cc. of amniotic 
fluid was withdrawn and centrifuged for 30 minutes at 3000 rpm. If still 
cloudy, it was then filtered through Whatman No. 1 paper with suction. 
Method I: 
The AO.D. (Liley) was determined by measuring the optical density 
of the amniotic fluid against distilled water from 365 my to 700 my in 
a continuous recording Perkin-Elmer 202 Spectrophotometer using 1 cm. 
path length cells (13). The tangent to the curve at approximately 365 
my and 550 my was drawn and height of the curve from the tangent at 450 
my was expressed in optical density units. 
Method II: 
Bilirubin was measured by the method of Fleming and Woolf (5) in 
the following manner. Using distilled water as a blank, the absorbance 
of the amniotic fluid was measured in 1 cm. path length cells at 700 my , 
623 my , 576 my, and 462 myin the Zeiss PM QII/M4 Oil Spectrophotometer. 
Fleming and Woolf described the addition of a few crystals of sodium 
dithionite to the amniotic fluid, repeating the reading at 700 my, and 
using the lower of the two readings at this wavelength. This author, 
however, has found that addition of sodium dithionite invariably in¬ 
creases the absorbance at 700 my , and therefore this chemical was not 
added. Bilirubin, in mg./100 ml., was calculated using the formula: 
Bilirubin = 1.25D - 0.91C - 1.15B + 0.11A, where A = O.D. at 700 my, 




Bilirubin was then measured by the method of Robertson (19). 
Reagents: 
(1) Diazo A: Sulfanilic acid, 1 gm. in 1000 ml. of hydro¬ 
chloric acid solution prepared by mixing 15 ml. of 
concentrated HC1 with water to make 1000 ml. 
Diazo B: Sodium nitrite 0.5%, made fresh daily by adding 
0.1 ml. of 50% stock solution of sodium nitrite to 
9.9 ml. of water. The sodium nitrite stock solution 
is kept refrigerated. 
Diazo solution: Add 0.3 ml. of solution B to 10 ml. 
of solution A. Make fresh daily. 
(2) Hydrochloric acid solution: Mix 15 ml. of concentrated 
HC1 to water to make 1000 ml. 
(3) Methanol 
Method: 
The following solutions were prepared: 
(A) 2 ml. amniotic fluid, 1 ml. diazo solution, and 3 ml. 
HC1 solution. 
(B) 2 ml. amniotic fluid and 4 ml. HC1 solution. 
(C) 2 ml. amniotic fluid, 1 ml. diazo solution, and 3 ml. 
methanol. 
(D) 2ml. amniotic fluid, 3 ml. methanol, and 1 ml. HC1 
solution. 
All solutions were allowed to stand for 10 minutes. Solution 
B was read against A to determine direct bilirubin, and D against 
C to determine total bilirubin. 
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All optical density measurements were made in 1 cm. path length 
cuvettes at 530 mp in the Zeiss PM QII/M4 Spectrophotometer. 
Robertson did not describe preparation of standards, but they can 
be prepared by adding commercial bilirubin in chloroform solution 
to methanol and substituting for methanol in solutions C and D. 
Method IV: 
Bilirubin was then measured by the method of Bower and Swale (2) . 
Reagents: 
(1) Diazo reagent: Solution A: 1 gm. sulfanilic acid in 
1000 ml. of 0.175 N HC1. Solution B: 0.5% sodium 
nitrite, prepared as described above. 
Ten ml. of A was mixed with 0.3 ml. of B. After 
5 minutes 1 ml. of 1.5% ammonium sulfamate was added, 
and the reagent was used after standing for at least 
3 minutes. 
Blank reagent was made by substituting distilled water 
for solution B in the diazo reagent. 
(2) Ethanol-urea solution: 25 gm. of urea was dissolved 
in 100 ml. of 85% (v/v) ethanol by heating. The 
solution was filtered through glass wool while still 
warm and kept in an incubator to prevent crystallization 
of urea. 
(3) Sodium azide, powder. 
(4) Phenol, liquid, 88% (Mallinkrodt). 
(5) Neutral buffer: 5.0 gm. of sodium citrate was dissolved 
in distilled water and made up to 100 ml. 
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(6) Acid buffer: 11.8 gm. of sodium citrate was dissolved 
in 0.2 N HC1 to a volume of 200 ml. and this was made 
up to 500 ml. with distilled water. 
(7) Chloroform 
Method: 
Amniotic fluid, 0.5 ml., was put in each of two 10 ml. test 
tubes. To the first was added 0.5 ml. of diazo reagent, and to the 
second, 0.5 ml. of blank reagent. Both tubes were placed in a beaker 
containing ice-colled water. Ethanol-urea, 2.2 ml., and 0.2 ml. of 
chloroform was added, and the tubes were mixed and allowed to stand 
in the ice water for 10 minutes. After removal from the ice, a tiny 
fragment of sodium azide was added to each tube and dissolved by shak¬ 
ing. Neutral buffer, 0.1 ml., was added followed by mixing. Phenol, 
2.5 ml., was added by burette into each tube and the tubes were vigor¬ 
ously mixed with a Vortex-Genie mixer. The diazo mixture was read 
against the blank at 530 my in 3 cm. path length cuvettes using the 
Zeiss PM Q11/M4 Qll Spectrophotometer. 
Standards were prepared from bilirubin 1 mg./ml. in chloroform 
(Fisher). This was used in the reaction mixture in place of chloro¬ 
form, and acid buffer was used instead of amniotic fluid. Appropriate 
dilutions of the bilirubin standard were made in chloroform to give 
bilirubin concentrations equivalent to 2.0, 1.0, 0.5, 0.25, and 0.125 
mg./lOO ml. in amniotic fluid. 
Method V: 
Bilirubin was then measured by the Jendrassik-Grof method as 
described by Gambino (9) . Proportions of the reagents have been changed 






(1) Caffeine mixture: 50 gm. of caffeine, 75 gin. of sodium 
benzoate, and 125 gm. of sodium acetate (-SH^O) were 
added to distilled water at 50-60°C., and the volume 
was brought up to 1000 ml. when cool. It was then fil¬ 
tered through glass wool. 
(2) Diazo A: 5.0 gm. sulfanilic acid and 15.0 ml. of concen¬ 
trated hydrochloric acid were added together and the vol¬ 
ume brought up to 1000 ml. It was then filtered through 
glass wool. 
Diazo B: 0.5% sodium nitrite solution was prepared as 
described above. 
Diazo reagent was prepared by mixing 10.0 ml. of Diazo/A 
with 0.25 ml. of Diazo B. Diazo reagent was made fresh 
daily. 
(3) Alkali mixture: 100 gm. of sodium hydroxide and 350 gm. 
of potassium sodium tartrate were dissolved in distilled 
water and the volume brought up to 1000 ml. It was fil¬ 
tered through glass wool. 
Method: 
Caffeine mixture, 1.0 ml., was added to each of 2 tubes, labeled 
unknown and blank. To each tube was added 0.5 ml. of amniotic fluid. 
After the addition of 0.17 ml. of Diazo reagent to the unknown tube 
and 0.17 ml. of Diazo A to the blank, both tubes were mixed and al¬ 
lowed to stand for 10 minutes, after which 0.5 ml. of alkali mixture 
was added and the tubes again shaken. Within 30 minutes, the optical 
. 
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density of the unknown was measured against the blank, using 1 cm. 
light path cuvettes in the Zeiss PM QII/M4 Oil spectrophotometer. 
Standards were prepared as follows. Bilirubin powder, 20 mg., 
(Eastman) was weighed to within 0.1 mg. in a tiny aluminum foil "boat' 
which was then pushed to the bottom of a 100 ml. volumetric flask so 
that all the bilirubin was deposited at the bottom of the flask. In 
subdued light 4 ml. of 0.1 N NaOH was added and the bilirubin dissolved 
by swirling. Fifty ml. of 1.5 gm. per cent human serum albumin in 
normal saline, prepared from pooled concentrated human serum albumin 
(American National Red Cross) , was then added and the contents of the 
flask again swirled. Four ml. of 0.1 N HC1 was added to neutralize the 
alkali, and 1.5% albumin was added to bring the volume up to 1000ml. 
Using the albumin solution and saline, solutions of 2.0, 1.0, 0.5, 
0.25, and 0.10 mg. per cent bilirubin in 0.75 gm. per cent albumin 
were prepared and subjected to diazotization in the same manner as 
amniotic fluid. 
The following tests were performed on amniotic fluid samples: 
AO.D. (Liley) all samples 
Bilirubin (Fleming - Woolf) 85 samples 
Bilirubin (Bower - Swale) 58 samples 
Bilirubin (Robertson) 20 samples 
Bilirubin (Jendrassik - Grof) 51 samples 
The values obtained by each method were plotted as the abcissa 
versus the corresponding AO.D. (Liley) values as ordinates. The best 




Equation of line is Y = a + 8X where 
_ EYEX2 - EXEXY 
“ ~ NEX2 - (EX)2 
NEXY - EXEY 
3 -~NEXZ - (EX)z 
The coefficient of correlation (r) was calculated as follows: 
NEXY - EXEY 
r = — ■ - ■■ - 
/ {NEXZ - (EX)z} {NEYZ - (EY)2} 
The standard error of estimate is found by the following calcu¬ 
lation : 
s 
(qEY + 3EXY) 
N 
The standard deviation of repeated measurements made on the same sam- 
r^2 
pie is: a =/ —, where x is the deviation of each measurement from 
the mean and N is the number of samples. 
For the Jendrassik-Grof method the molar absorptivity of alk¬ 
aline azobilirubin was calculated from this equation: 
24 ^ GOO™!-1 _ M.W. • A/cm. • final volume in ml. 
‘1cm. Total amount of bilirubin in mg. 
Where M.A.^^mh = Molar absorptivity at 600 my for 1 cm. light path, 
M.W. = Molecular weight of bilirubin (584), A/cm. = Absorptivity per 
cm. of light path. 
As suggested by Gambino (9), the molecular weight of bilirubin 

























0.94 0.046 0.043 
Fleming-Woolf AO.D.= 
-0.016+0.59Bili 
0.96 0.034 0.01 
Jendrassik-Grof AO.D.* 
-0.025+0.74Bili 
0.99 0.024 0.021 
Robertson Unusable ,_ _ __ 
(See text) 
Bilirubin was measured by the Fleming-Woolf method in 85 
samples and the comparison between these values and the AO.D. 
(Liley) is shown in Figure 1. 
The Bower-Swale method was used to measure bilirubin in 
58 samples, and the plot against AO.D. is shown in Figure 2. The 
standardization curve for the Bower-Swale method is shown in Figure 3. 
Bilirubin in 51 samples was measured using the Jendrassik- 
Grof method and the results are plotted against AO.D. in Figure 4. 
The standardization curve is shown in Figure 5. The molar ab¬ 
sorptivity of azobilirubin is calculated to be 72,500. 





Robertson's method for measuring total bilirubin gave solutions 
with such a great amount of turbidity that they could not be read in 
the spectrophotometer, and therefore it could not be used. The dir¬ 
ect bilirubin was negligible in the 20 samples tested, and therefore 
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Liley's AO.D. method for measuring amniotic fluid bilirubin was 
the first to be suggested, and it became immediately popular. Being a 
direct spectrophotometric method, no reagents were required. Although 
a continuous recording spectrophotometer is not absolutely necessary, 
with a manual instrument readings must be made at twelve individual 
wavelengths. Not only must the spectrophotometer be linear at every 
wavelength, it must be absolutely accurate at every wavelength. Be¬ 
cause there is no standardization with known bilirubin samples, re¬ 
sults must be expressed in "optical density units" and workers using 
two different spectrophotometers have no way of knowing whether their 
results are in agreement. 
Walker, Fairweather and Jones (21) used a direct spectrophoto¬ 
metric method similar to Liley's except that per cent transmission 
instead of optical density was plotted against wavelength. The distance 
from the tangent to the curve itself at 450 my was measured and ex¬ 
pressed as a difference in per cent transmission. The disadvantage of 
this method is that it is optical density, not per cent transmission, 
which is proportional to the amount of pigment present, so that when 
per cent transmission is used, the presence of varying amounts of 
turbidity in the amniotic fluid will change the estimate of bilirubin 
present. 
Fleming and Woolf quantitated a direct spectrophotometric method 
for measuring bilirubin (5). They found that the four factors which 
contributed to the optical density of amniotic fluid were bilirubin, 
turbidity, and oxyhemoglobin and methemalbumin if present. By per- 
- 
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forming spectrophotometric scans on these components in pure form, 
it was possible to find the wavelengths of greatest absorption for 
each of them. The optical densities of the four substances were found 
at each of four wavelengths, one for each component, and from the re¬ 
lation between these and the knowledge of the absorbance of each pure 
substance, the bilirubin was calculated. As with the AO.D. (Liley) 
method, the spectrophotometer must be absolutely accurate at the four 
wavelengths used. 
Other workers have used diazo reactions for quantitating 
bilirubin, although some have questioned their use. Liley believed 
that accuracy would be decreased by dilutional errors and by 
deterioration of reagents (13). Freda (7) stated that chemical tests 
for amniotic fluid bilirubin were undesirable, since he believed that 
bilirubin was just one of many similar pigments from hemoglobin 
breakdown, all of which absorb between 400 my and 500 my, and there¬ 
fore concluded that the AO.D. was a more accurate indication of the 
fetal status. 
Using reverse phase Kieselguhr column chromatography, however, 
Brazie et al. demonstrated that the pigment in amniotic fluid is only 
bilirubin, so that this objection has been overcome (3). 
The diazo methods that have been employed are adaptations of 
methods in use for serum, often with a greater proportion of amniotic 
fluid in the reaction mixture to intensify the final color. Although 
significant levels of bilirubin are often as low as 0.1 mg. per cent, 
protein levels are often greater than 1 gm. per cent (4) , and coupling 




preventing the measurement of the bilirubin present. 
Robertson (19), and Watson et al. (22) used a modified Malloy- 
Evelyn method employing as a coupling agent methanol, which pre¬ 
cipitates protein. Robertson also measured the direct bilirubin by 
omitting the coupling reagent, and by subtracting the direct from 
the total bilirubin, obtained the indirect which he believed was 
more accurate that the AO.D. in predicting fetal outcome. Only 
four poorly defined categories of fetal outcome were used, and out 
of a total of 252 predictions based on the aO.D., of which 193 were 
correct and 59 incorrect, 23 could be corrected by considering only 
the indirect bilirubin. It was not noted, however, how many correct 
predictions based on the aO.D. would be "uncorrected" by considering 
the indirect bilirubin, and therefore the two methods were not com¬ 
pared in a meaningful manner. 
Michaelsson (16), using the Malloy-Evelyn method on serum, found 
that turbidity of the blank solution varied from time to time and from 
sample to sample. Other disadvantages of the Malloy-Evelyn technique 
are the long period, 30 minutes, required for complete diazotization 
and the low sensitivity. Because of the low bilirubin level in amnio- 
tic fluid compared to serum, the disadvantages of the Malloy-Evelyn 
method should be even more serious when applied to amniotic fluid meas¬ 
urements . 
Robertson did not mention problems caused by turbidity of the 
reaction mixtures containing methanol, but this writer has found that 
the diazo and blank tubes often have different degrees of turbidity, 
making it impossible to ascribe the difference in optical density bet- 
■ V 
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ween the two tubes as being related in any way to the amount of bili¬ 
rubin present. Often the optical density due to turbidity was ten 
times as great as that estimated to be caused by the bilirubin. For 
these reasons diazotization with methanol was found to be totally 
unsatisfactory. 
Bower and Swale employed the diazo method of Patterson, Swale 
and Maggs (17), in which coupling is effected by ethanol-urea sol¬ 
ution which precipitates protein, excess diazo reagent is then in¬ 
activated by sodium azide, and finally the precipitated protein is 
redissolved with phenol. The resulting solutions are optically clear, 
but the concentrations of ethanol and phenol required are quite large, 
necessitating a 1:12 dilution of the amniotic fluid before the final 
solution to be read in the spectrophotometer is obtained; consequently, 
the sensitivity of the method is low. Bower and Swale expressed results 
for the assay of bilirubin as "positive" or "negative," and all pos¬ 
itives were listed as having bilirubin greater than 0.12 mg. per cent, 
implying that levels below this value could not be accurately determined. 
This writer has confirmed this lack of accuracy. Repeated measure¬ 
ments on the same sample gave a standard deviation of 0.043, the high¬ 
est of all methods tested with the exception of Robertson’s. One of 
the difficulties was the lack of miscibility of phenol and the ethanol- 
water solutions, even after vigorous agitation using a mechanical mix¬ 
er. When placed in the cuvette, striations would form in the sol¬ 
ution which would not respond to all attempts at removing them, from 
stirring with a glass rod to blowing fine bubbles through the solution 
■ 
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with a Pasteur pipette. Once striations formed, optical density- 
measurements on the solution were not repeatable. 
Jendrassik and Grof developed a diazo method making use of a 
caffeine-sodium benzoate coupling reagent that did not precipitate 
protein (12). After diazotization, the reaction mixture was brought 
to alkaline pH, producing a blue color which was more specific for 
bilirubin than the pink azobilirubin formed at acid pH. Fog (6) 
found that the protein concentration of the sample did not affect 
the degree of diazotization within a fiftyfold dilution of serum. 
Duplicate determinations on 43 different serum samples showed a 
mean difference of less than 1%. The green color of the final 
reaction mixture was noted to be a combination of blue alkaline 
azobilirubin and the yellow color formed by the reaction of diazo 
reagent with caffeine at alkaline pH. At 600 my this yellow pigment 
absorbed a negligible amount of light, and therefore did not inter¬ 
fere with the bilirubin determination even in weak solutions. 
Michaelsson found that hemoglobin in concentrations up to 280 mg. 
per cent inhibited diazotization to cause an apparent loss in 
measured bilirubin of only 2%, which increased to 8% at a hemoglobin 
concentration of 1400 mg. per cent (16). The addition of ascorbic 
acid to the diazotization reaction mixture prevented inhibition by 
hemoglobin. 
Gambino and Freda adapted the Jendrassik-Grof method to the 
measurement of bilirubin in amniotic fluid (10). The equation of 
the best straight line comparing AO.D. and bilirubin was 
AO.D. = -0.011 + 0.74 Bilirubin. The coefficient of correlation 
for that plot was 0.99, and the molar absorptivity of azobilirubin 




was 72,500, within 0.7% of that found by them. The equation of the 
best straight line was AO.D. = -0.025 + 0.74 Bilirubin. The slopes 
determined by this writer and Gambino are the same, 0.74, and the 
AO.D. intercepts differ by 0.014 optical density units, so that the 
AO.D. as determined by this writer is uniformly 0.01 optical den¬ 
sity unit lower than that determined by Gambino, an insignificant 
difference practically. 
In addition to using different coupling agents, the three 
diazo methods tested here employ three different types of standards. 
The Bower-Swale, Malloy-Evelyn, and Jendrassik-Grof methods use bili¬ 
rubin standards prepared in chloroform, methanol and human serum 
respectively. 
The Subcommittee on Bilirubin of the Standards Committee of the 
American Association of Clinical Chemists defined an acceptable stand¬ 
ard (18). They decreed that standards must be prepared in fresh human 
serum, and that the standard must be treated in exactly the same man¬ 
ner as the sample whose bilirubin is to be measured. 
Using the Malloy-Evelyn method, however, Meites and Traubert (15) 
found that standards of bilirubin in chloroform-methanol gave the same 
molar absorptivity as standards in aqueous serum solution, if correction 
was made for the volume contraction of methanol-water solutions. 
The Bower-Swale standardization employs chloroform solutions of 
bilirubin, and also differs from the Subcommittee recommendations in 
that the standards and the amniotic fluid are treated differently; the 
reaction mixture contains acid buffer instead of amniotic fluid and 
bilirubin in chloroform instead of pure chloroform. 
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Therefore the Jendrassik-Grof method is the only one tested 
that as published uses standards in conformity with Subconnittee 
recommendations. This writer used concentrated pooled human serum 
albumin in the preparation of standards since fresh human serum was 
not available in sufficient quantities. The molar absorptivity of 
azobilirubin was within 0.7% of that calculated by Gambino using 
serum, so that pooled human albumin is shown to be a convenient ac¬ 
ceptable source of protein. 
Fleming and Woolf developed their equation by measuring the 
optical density of bilirubin standards in aqueous protein solutions, 
and the molar absorptivity of bilirubin solutions are recognized as 
potentially inaccurate unless they are highly purified (11) . 
The methods studied in this paper gave varying results in meas¬ 
uring bilirubin; the graphs comparing AO.D. with bilirubin for the 
Fleming-Woolf, Bower-Swale, and Jendrassik-Grof methods were 0.59, 
0.66, and 0.74 respectively. This may be a reflection of the dif¬ 
ferent types of standards used by each method as well as the different 
coupling agents used for diazotization, since varying values for bili¬ 
rubin determinations in serum using different methods are will known 
(23). 
It is essential that amniotic fluid bilirubin analyses be per¬ 
formed using a method which is accurate and repeatable by different 
workers using differing equipment. There is evidence that the AO.D. 
(Liley) method is not suitable. While it is repeatable to within 0.01 
optical density unit when all measurements are made on the same spect¬ 
rophotometer, varying readings may be obtained when different instru¬ 




the Cary automatic recording spectrophotometer is consistently lower 
than that obtained using the Beckman DU Spectrophotometer. Robertson 
suggested that because the AO.D. method does not give consistent re¬ 
sults when performed by different laboratories, it is probably nec¬ 
essary for each worker to determine his own laboratory's critical AO.D. 
values for patient management. Until these critical values have been 
determined, however, many fetuses would have to be poorly managed, mere¬ 
ly in order to obtain statistics. 
Many workers involved in management of erythroblastosis, fur¬ 
thermore, see too few patients to deduce a method of management on 
their own. In an attempt to deal statistically with a larger series 
of patients, the Ross Conference on Pediatric Research (20) gathered 
many workers in erythroblastosis to pool their findings. Such cooper¬ 
ative studies may be meaningless, however, if the AO.D. values are not 
consistent among the laboratories reporting. 
Of the methods tested in this paper, the Jendrassik-Grof is most 
suitable for replacing direct spectrophotometry. This writer and 
Gambino have found its correlation with the AO.D. (Liley) to be 0.99, 
and both have obtained a value of 0.74 for the slope of the graph of 
AO.D. versus bilirubin. Of all methods tested, the Jendrassik-Grof had 
the lowest standard error of estimate, 0.024 optical density units. 
The spectrophotometer need not be of the continuous recording type, 
and since standards are used, it must only be linear at one wave¬ 
length. 
Workers who have accumulated large quantities of data using 
direct spectrophotometry and who wish to use the Jendrassik-Grof 




two methods and then convert the previously obtained AO.D. values 
into mg. per cent bilirubin, with no loss of continuity in their 
statistics. 
With consistent and standardized techniques for measuring 
bilirubin, amniocentesis will be still more useful in the manage¬ 
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